Back to search

University of Crete (UOC)

Λοιμώξεις σε ασθενείς με συμπαγείς όγκους: επίπτωση, μικροβιολογία, παράγοντες κινδύνου και έκβαση

Abstract

dc:description

Solid tumors represent the most common form of malignancy, accounting for the majority of new cancer diagnoses and cancer-related deaths worldwide. Despite substantial advances in diagnostic and therapeutic strategies, infections remain a leading cause of morbidity and mortality, primarily due to immunosuppression and the presence of indwelling medical devices. These infections adversely affect disease progression, survival, and quality of life. The constantly evolving epidemiology and the increasing prevalence of antimicrobial resistance pose major challenges to their management, with accurate diagnosis and appropriate empirical therapy being critical determinants of favorable outcomes.This doctoral thesis is a prospective epidemiological study documenting and monitoring infections in patients with solid tumors hospitalized in the two oncology departments of the hospitals of Heraklion, Crete (University General Hospital of Heraklion and Venizeleio General Hospital of Heraklion) over a two-year period (January 2020 to December 2021).A total of 282 infection episodes were recorded among hospitalized patients with solid tumors undergoing active anticancer therapy, predominantly chemotherapy (89.4%), with a mean age of 66±12 years.The most frequent underlying malignancy was lung cancer, recorded in 87 patients (30.8%), followed by colorectal cancer in 44 patients (15.6%). Regarding comorbidities, arterial hypertension (106 patients; 37.6%), diabetes mellitus (71; 25.2%), dyslipidemia (54; 19.1%), and cardiovascular disease (37; 13.1%) were the most common.Risk factors such as mucositis and surgery in the preceding month were documented in 24 (8.5%) and 10 (3.5%) patients, respectively. Antimicrobial administration in the preceding three months was recorded in 51.1% of patients, while 39% had been hospitalized during the same period. Central venous catheters (CVC) were present in 45% of patients, and another 25.2% had other foreign bodies. Corticosteroids were administered in 18.1%, and granulocyte colony-stimulating factor (GCSF) in 67.7%.With respect to microbiology, Gram-negative bacteria predominated over Gram-positive (123 [54.7%] vs. 103 [45.6%]), and 101 isolates (44.7%) were multidrug-resistant (MDR). In polymicrobial infections, the occurrence of polymicrobial bloodstream infection (BSI) was significantly associated with worse patient outcomes and increased infection-related mortality (p=0.009 and p=0.008, respectively).Sixty-three patients (22.3%) were diagnosed with febrile neutropenia (FN), 66 (19.9%) with primary BSI, and 46 (16.3%) with lower respiratory tract infection.In the FN subgroup (n=63), the most frequent underlying malignancy was lung cancer (38.1%). The median duration of neutropenia was 3 days (range: 1–10), and the presence and duration of mucositis were significantly associated with neutropenia lasting ≥3 days (p=0.012). Neutropenia of ≥3 days was also significantly associated with patient outcomes (p=0.050). Positive cultures were obtained in 34.9% of cases, with Gram-positive bacteria being the most frequently isolated pathogens from blood cultures—likely related to the high proportion of patients with CVCs (39.7%). The infection source remained unknown in 44.4% of FN cases. Most patients showed improvement or complete resolution (74.6% and 12.7%, respectively). Comparative analysis between FN and non-FN patients revealed significant differences in age (p=0.04), GCSF use (p=0.002), and immunotherapy administration (p=0.004). Moreover, in this group, worse performance status (PS) according to the Eastern Cooperative Oncology Group (ECOG) scale was associated with higher mortality (p=0.061), particularly markedly impaired PS (p=0.004).For BSI patients, clinical characteristics, microbiology, and outcomes were analyzed. All BSI cases had positive blood cultures, with polymicrobial infection documented in 28.8%. Mortality was significantly higher among males (p=0.025), those with poorer PS, and those with antimicrobial resistance (p < 0.001). Additionally, all patients who underwent radiotherapy died (p=0.002), while the presence of infection was associated with higher mortality (100% vs 14.5%, p<0.001) and was strongly associated with the cause of death (75% vs 14.5%, p=0.003). Impaired functional status (PS ≥ 2) was also associated with increased risk of severe infections and death.In terms of overall outcomes, most patients (211; 74.8%) were discharged from the hospital. Forty-five patients (16%) died, with 22 deaths (48.9%) directly attributable to infection. Several additional risk factors were linked to higher risk of severe infections and death; among these, poor functional status (ECOG PS ≥ 2) and disease response were statistically significant (p < 0.001), while prior hospitalization was also associated with worse outcomes (p = 0.019). Finally, polymicrobial infections were more frequently associated with complications and higher mortality.This doctoral thesis highlights the local epidemiology of infections in patients with solid tumors receiving active anticancer therapy. The findings demonstrate that infections in this population constitute a major cause of morbidity and mortality among hospitalized patients undergoing active treatment. FN, BSIs, and lower respiratory tract infections were the most frequent clinical syndromes, with Gram-negative organisms predominating over Gram-positive, and a considerable proportion being polymicrobial and caused by MDR pathogens.The results underscore the need for an individualized approach to the management of oncology patients with infections, with emphasis on appropriate empirical antimicrobial therapy, early identification of high-risk groups, and the implementation of multicenter studies to establish optimal prevention and treatment strategies.

Degree

thesis:*
Grantor dc:publisher
University of Crete (UOC)
Year dc:date
2025

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Bachlitzanaki, Maria
  • Μπαχλιτζανάκη, Μαρία

Subjects

dc:subject × 18

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/59850

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Bachlitzanaki, Maria; Μπαχλιτζανάκη, Μαρία. Λοιμώξεις σε ασθενείς με συμπαγείς όγκους: επίπτωση, μικροβιολογία, παράγοντες κινδύνου και έκβαση. University of Crete (UOC), 2025. http://hdl.handle.net/10442/hedi/59850